688222 成都先导
已收盘 07-14 15:00:02
资讯
新帖
简况
成都先导合作伙伴Bioage Labs启动BGE-102二期试验，首例受试者完成给药
美股速递 · 07-14 16:30
成都先导合作伙伴Bioage Labs启动BGE-102二期试验，首例受试者完成给药
每周股票复盘：成都先导（688222）放弃参股公司优先认购权
证券之星 · 07-12 01:27
每周股票复盘：成都先导（688222）放弃参股公司优先认购权
7月10日成都先导涨7.23%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 07-10
7月10日成都先导涨7.23%，中证2000ETF华泰柏瑞基金重仓该股
每周股票复盘：成都先导（688222）股东减持致持股比降至10%
证券之星 · 07-05
每周股票复盘：成都先导（688222）股东减持致持股比降至10%
7月1日成都先导发布公告，股东减持170.28万股
证券之星 · 07-01
7月1日成都先导发布公告，股东减持170.28万股
每周股票复盘：成都先导（688222）召开2026年第二次临时股东会
证券之星 · 06-28
每周股票复盘：成都先导（688222）召开2026年第二次临时股东会
成都先导（688222）披露2026年第二次临时股东会决议公告，6月24日股价上涨0.13%
证券之星 · 06-24
成都先导（688222）披露2026年第二次临时股东会决议公告，6月24日股价上涨0.13%
6月23日成都先导涨7.29%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 06-23
6月23日成都先导涨7.29%，中证2000ETF华泰柏瑞基金重仓该股
6月1日成都先导跌7.49%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 06-01
6月1日成都先导跌7.49%，中证2000ETF华泰柏瑞基金重仓该股
每周股票复盘：成都先导（688222）2025年度股东会顺利召开
证券之星 · 05-31
每周股票复盘：成都先导（688222）2025年度股东会顺利召开
成都先导（688222）披露2025年年度股东会决议公告，5月29日股价下跌0.6%
证券之星 · 05-29
成都先导（688222）披露2025年年度股东会决议公告，5月29日股价下跌0.6%
5月26日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 05-26
5月26日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股
成都先导（688222）新增【AI智能体】概念
证券之星 · 05-25
成都先导（688222）新增【AI智能体】概念
每周股票复盘：成都先导（688222）完成对先衍生物增资
证券之星 · 05-24
每周股票复盘：成都先导（688222）完成对先衍生物增资
成都先导（688222）披露关于增资参股公司进展暨完成工商变更登记的公告，5月22日股价上涨5.3%
证券之星 · 05-22
成都先导（688222）披露关于增资参股公司进展暨完成工商变更登记的公告，5月22日股价上涨5.3%
5月18日成都先导跌6.02%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 05-18
5月18日成都先导跌6.02%，中证2000ETF华泰柏瑞基金重仓该股
5月15日成都先导涨5.06%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 05-15
5月15日成都先导涨5.06%，中证2000ETF华泰柏瑞基金重仓该股
每周股票复盘：成都先导（688222）拟每10股派1.3元
证券之星 · 05-10
每周股票复盘：成都先导（688222）拟每10股派1.3元
【机构调研记录】德邦基金调研成都先导、盛弘股份
证券之星 · 05-08
【机构调研记录】德邦基金调研成都先导、盛弘股份
成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%
证券之星 · 05-07
成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%
加载更多
公司概况
公司名称：
成都先导药物开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2020-04-16
主营业务：
成都先导药物开发股份有限公司的主营业务是药物研发并提供技术咨询、技术转让和技术服务等。公司的主要产品是新药研发服务、新药在研项目权益转让。
发行价格：
20.52
{"stockData":{"symbol":"688222","market":"SH","secType":"STK","nameCN":"成都先导","latestPrice":35.52,"timestamp":1784012402000,"preClose":35.53,"halted":0,"volume":26690586,"delay":0,"changeRate":-0.0003,"floatShares":401000000,"shares":401000000,"eps":0.3063,"marketStatus":"已收盘","change":-0.01,"latestTime":"07-14 15:00:02","open":34.8,"high":36.2,"low":33,"amount":925000000,"amplitude":0.0901,"askPrice":35.54,"askSize":36,"bidPrice":35.52,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.3063,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784079000000},"marketStatusCode":5,"adr":0,"adjPreClose":35.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783992600000,1783999800000],[1784005200000,1784012400000]],"highLimit":39.08,"lowLimit":31.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400680000,"isCdr":false,"pbRate":9.25,"roa":"--","peRate":115.96474,"roe":"2.73%","epsLYR":0.27,"committee":0.778032,"marketValue":14232000000,"turnoverRate":0.0666,"status":1,"afterMarket":{"amount":0,"volume":0,"close":35.52,"buyVolume":44795,"sellVolume":0,"time":1784014437746,"indexStatus":"已收盘 07-14 15:30:00","preClose":35.53},"floatMarketCap":14232000000},"requestUrl":"/m/hq/s/688222","defaultTab":"news","newsList":[{"id":"1163644751","title":"成都先导合作伙伴Bioage Labs启动BGE-102二期试验，首例受试者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1163644751","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163644751?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:30","pubTimestamp":1784017817,"startTime":"0","endTime":"0","summary":"成都先导的合作伙伴Bioage Labs宣布，其用于降低心血管风险的新型口服NLRP3抑制剂BGE-102，已启动二期临床试验并为首例参与者完成给药。该候选药物旨在通过靶向炎症通路来应对心血管疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650151421","title":"每周股票复盘：成都先导（688222）放弃参股公司优先认购权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650151421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650151421?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:27","pubTimestamp":1783790829,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，成都先导报收于35.87元，较上周的32.41元上涨10.68%。本周，成都先导7月10日盘中最高价报36.9元。公司公告汇总成都先导药物开发股份有限公司拟放弃对参股公司成都先衍生物技术有限公司A+轮融资中增资扩股的优先认购权。放弃认购后，成都先导持股比例由21.40%降至20.55%。成都先导药物开发股份有限公司为规范项目跟投计划，调动核心员工积极性，制定《核心员工跟投创新业务管理办法》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650592183","title":"7月10日成都先导涨7.23%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650592183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650592183?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:20","pubTimestamp":1783671658,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日成都先导涨7.23%创60日新高，收盘报35.87元，换手率8.44%，成交量33.82万手，成交额11.94亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.5174，较上一交易日上涨1.7%，近一年上涨29.98%。中证2000ETF华泰柏瑞的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000028688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["563300","BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694983","title":"每周股票复盘：成都先导（688222）股东减持致持股比降至10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694983","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649694983?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:17","pubTimestamp":1783189030,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，成都先导报收于32.41元，较上周的30.5元上涨6.26%。本周，成都先导7月2日盘中最高价报34.5元。本次权益变动后，持股比例由10.92%减少至10.00%，触及5%整数倍。成都先导药物开发股份有限公司简式权益变动报告书拉萨经济技术开发区华博医疗器械有限公司因自身资金需求，通过集中竞价和询价转让方式减持成都先导股份。自2021年5月26日至2026年6月30日，累计减持19,085,474股，持股比例由14.76%降至10.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648146345","title":"7月1日成都先导发布公告，股东减持170.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648146345","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648146345?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:01","pubTimestamp":1782900084,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日成都先导发布公告《成都先导:成都先导药物开发股份有限公司简式权益变动报告书》，其股东拉萨经济技术开发区华博医疗器械有限公司于2026年5月29日至2026年6月30日间合计减持170.28万股，占公司目前总股本的0.425%，变动期间该股股价上涨7.72%，截止6月30日收盘报32.11元。股东增减持详情见下表：根据成都先导2026年一季报公布的十大股东详情如下：本文数据来源于成都先导公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100035092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646431845","title":"每周股票复盘：成都先导（688222）召开2026年第二次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2646431845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646431845?lang=zh_cn&edition=full","pubTime":"2026-06-28 01:32","pubTimestamp":1782581531,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，成都先导报收于30.5元，较上周的27.53元上涨10.79%。本周，成都先导6月25日盘中最高价报32.19元。本周关注点来自公司公告汇总：成都先导于2026年6月24日召开第二次临时股东会，审议通过债务融资工具发行方案变更等议案。公司公告汇总成都先导药物开发股份有限公司于2026年6月24日召开2026年第二次临时股东会，会议由董事会召集，董事长JIN LI（李进）主持，采用现场与网络投票相结合方式举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819895","title":"成都先导（688222）披露2026年第二次临时股东会决议公告，6月24日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645819895?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:06","pubTimestamp":1782309983,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，成都先导报收于30.78元，较前一交易日上涨0.13%，最新总市值为123.33亿元。近日，成都先导药物开发股份有限公司发布《2026年第二次临时股东会决议公告》。北京君合（成都）律师事务所见证会议并出具法律意见书，认为会议决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400043714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029881","title":"6月23日成都先导涨7.29%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645029881?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:51","pubTimestamp":1782204679,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日成都先导涨7.29%，收盘报30.74元，换手率7.9%，成交量31.64万手，成交额9.61亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.6341，较上一交易日上涨0.81%，近一年上涨50.93%。中证2000ETF华泰柏瑞的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["563300","BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640932671","title":"6月1日成都先导跌7.49%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640932671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640932671?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:42","pubTimestamp":1780303350,"startTime":"0","endTime":"0","summary":"证券之星消息，6月1日成都先导跌7.49%，收盘报27.41元，换手率4.69%，成交量18.79万手，成交额5.31亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.5547，较上一交易日下跌3.33%，近一年上涨40.03%。中证2000ETF华泰柏瑞的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","563300","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601780","title":"每周股票复盘：成都先导（688222）2025年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601780?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:15","pubTimestamp":1780164912,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，成都先导报收于29.63元，较上周的31.6元下跌6.23%。本周，成都先导5月27日盘中最高价报33.98元。本周关注点来自公司公告汇总：成都先导2025年年度股东会审议通过利润分配预案及续聘审计机构等议案。公司公告汇总北京君合(成都)律师事务所就成都先导药物开发股份有限公司2025年年度股东会的召集和召开程序、出席人员资格、召集人资格、表决程序和表决结果出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639986673","title":"成都先导（688222）披露2025年年度股东会决议公告，5月29日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639986673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639986673?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:12","pubTimestamp":1780063944,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，成都先导报收于29.63元，较前一交易日下跌0.6%，最新总市值为118.72亿元。近日，成都先导药物开发股份有限公司发布《2025年年度股东会决议公告》。北京君合（成都）律师事务所对本次会议出具法律意见书，认为会议决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638592837","title":"5月26日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638592837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638592837?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:27","pubTimestamp":1779784065,"startTime":"0","endTime":"0","summary":"证券之星消息，5月26日成都先导涨5.44%创60日新高，收盘报33.31元，换手率7.5%，成交量30.04万手，成交额9.75亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.6347，较上一交易日上涨0.37%，近一年上涨51.81%。中证2000ETF华泰柏瑞的前十大重仓股如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600027329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","563300","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558513","title":"成都先导（688222）新增【AI智能体】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558513?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:30","pubTimestamp":1779712219,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，5月25日成都先导新增概念。成都先导2026年一季报显示，一季度公司主营收入1.61亿元，同比上升50.4%；归母净利润4150.02万元，同比上升46.72%；扣非净利润3963.36万元，同比上升126.4%；负债率23.26%，投资收益134.81万元，财务费用504.87万元，毛利率56.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","159819","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637781253","title":"每周股票复盘：成都先导（688222）完成对先衍生物增资","url":"https://stock-news.laohu8.com/highlight/detail?id=2637781253","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637781253?lang=zh_cn&edition=full","pubTime":"2026-05-24 01:28","pubTimestamp":1779557292,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，成都先导报收于31.6元，较上周的29.9元上涨5.69%。本周，成都先导5月22日盘中最高价报32.34元。成都先导当前最新总市值126.61亿元，在医疗服务板块市值排名14/51，在两市A股市值排名1693/5206。本周关注点公司公告汇总：成都先导以2,400万元完成对先衍生物增资，持股21.401%公司公告汇总成都先导于2026年2月9日召开董事会，审议通过增资参股公司成都先衍生物的议案，投前估值4.5亿元，以2,400万元认购其新增注册资本。成都先导持股比例为21.401%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310329","title":"成都先导（688222）披露关于增资参股公司进展暨完成工商变更登记的公告，5月22日股价上涨5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310329","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637310329?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:05","pubTimestamp":1779458705,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，成都先导报收于31.6元，较前一交易日上涨5.3%，最新总市值为126.61亿元。近日，成都先导发布《关于增资参股公司的进展暨完成工商变更登记的公告》。公告显示，公司于2026年2月9日召开董事会，审议通过增资参股公司成都先衍生物的议案，投前估值4.5亿元，以2,400万元认购其新增注册资本。截至目前，投资款已全额支付，先衍生物已完成工商变更登记，取得新营业执照。成都先导持股比例为21.401%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200044792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636256850","title":"5月18日成都先导跌6.02%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636256850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636256850?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:28","pubTimestamp":1779092915,"startTime":"0","endTime":"0","summary":"证券之星消息，5月18日成都先导跌6.02%，收盘报28.1元，换手率7.45%，成交量29.87万手，成交额8.62亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.6162，较上一交易日下跌0.66%，近一年上涨49.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["563300","688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704101","title":"5月15日成都先导涨5.06%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704101","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635704101?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:29","pubTimestamp":1778833790,"startTime":"0","endTime":"0","summary":"证券之星消息，5月15日成都先导涨5.06%，收盘报29.9元，换手率6.7%，成交量26.86万手，成交额7.99亿元。融资融券方面近5日融资净流出33.75万，融资余额减少；融券净流入200.0，融券余额增加。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.6269，较上一交易日下跌2.14%，近一年上涨48.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500029106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["563300","BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411850","title":"每周股票复盘：成都先导（688222）拟每10股派1.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411850?lang=zh_cn&edition=full","pubTime":"2026-05-10 01:13","pubTimestamp":1778346790,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，成都先导报收于27.0元，较上周的28.61元下跌5.63%。本周，成都先导5月7日盘中最高价报29.67元。本周关注点来自公司公告汇总：成都先导拟每10股派发现金红利1.3元（含税）。深圳钧天持有公司2.51%股份，计划于2026年5月13日至8月12日通过集中竞价和大宗交易方式减持其所持全部10,067,751股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633910607","title":"【机构调研记录】德邦基金调研成都先导、盛弘股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2633910607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633910607?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:06","pubTimestamp":1778198794,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月7日披露的机构调研信息，德邦基金近期对2家上市公司进行了调研，相关名单如下：1）成都先导 调研纪要：成都先导持续推进DEL+AI/ML在新药发现中的应用，构建HILO平台实现“设计-合成-测试-分析”闭环。2）盛弘股份 调研纪要：公司2026年一季度营收约7.44亿元，同比增长23.13%；归母净利润8518.42万元，同比增长16.86%。IDC部门已于2025年下半年成立，相关产品按计划研发推广。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800006527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0224","BK0156","300693","688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633141851","title":"成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633141851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633141851?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:40","pubTimestamp":1778146844,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，成都先导报收于29.04元，较前一交易日上涨0.14%，最新总市值为116.36亿元。该股当日开盘28.99元，最高29.67元，最低28.65元，成交额达5.94亿元，换手率为5.11%。近日，成都先导药物开发股份有限公司发布《2025年年度股东会会议资料》。公告显示，公司拟召开2025年年度股东大会，会议定于2026年5月29日以现场与网络投票相结合方式举行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784046933112,"stockEarnings":[{"period":"1week","weight":0.1065},{"period":"1month","weight":0.367},{"period":"3month","weight":0.2863},{"period":"6month","weight":-0.0456},{"period":"1year","weight":0.9742},{"period":"ytd","weight":0.5221}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0149},{"period":"6month","weight":-0.0354},{"period":"1year","weight":0.1271},{"period":"ytd","weight":-0.0004}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都先导药物开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"25798人(较上一季度增加25.56%)","perCapita":"15531股","listingDate":"2020-04-16","address":"四川省成都市武侯区高新区科园南路88号1栋3层","registeredCapital":"40068万元","survey":" 成都先导药物开发股份有限公司的主营业务是药物研发并提供技术咨询、技术转让和技术服务等。公司的主要产品是新药研发服务、新药在研项目权益转让。","listedPrice":20.52},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成都先导(688222)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成都先导(688222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成都先导,688222,成都先导股票,成都先导股票老虎,成都先导股票老虎国际,成都先导行情,成都先导股票行情,成都先导股价,成都先导股市,成都先导股票价格,成都先导股票交易,成都先导股票购买,成都先导股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成都先导(688222)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成都先导(688222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}